{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:39:50Z","timestamp":1791135590105,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.lungcan.2006.06.019","type":"journal-article","created":{"date-parts":[[2006,8,25]],"date-time":"2006-08-25T15:43:13Z","timestamp":1156520593000},"page":"235-240","source":"Crossref","is-referenced-by-count":97,"title":["Multidrug resistance in small cell lung cancer: Expression of P-glycoprotein, multidrug resistance protein 1 and lung resistance protein in chemo-naive patients and in relapsed disease"],"prefix":"10.1016","volume":"54","author":[{"given":"Nadja","family":"Triller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Koro\u0161ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izidor","family":"Kern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitja","family":"Ko\u0161nik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"Debeljak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 5","key":"10.1016\/j.lungcan.2006.06.019_bib1","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1093\/annonc\/10.suppl_5.S83","article-title":"Multidrug resistance in non-small cell lung cancer","volume":"10","author":"Scagliotti","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1016\/j.lungcan.2006.06.019_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.bi.58.070189.001033","article-title":"The biochemistry of P-glycoprotein-mediated multidrug resistance","volume":"58","author":"Endicott","year":"1989","journal-title":"Ann Rev Biochem"},{"key":"10.1016\/j.lungcan.2006.06.019_bib3","first-page":"357","article-title":"Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs","volume":"54","author":"Grant","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2006.06.019_bib4","series-title":"Lung Cancer","first-page":"156","article-title":"Chemotherapy of small cell lung cancer","author":"Smith","year":"1995"},{"key":"10.1016\/j.lungcan.2006.06.019_bib5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1023\/A:1022687617318","article-title":"Simultaneous modulation of multidrug resistance and antiapoptotic cellular defence by MDR1 and BCL2 targeted antisense oligonucleotides enhances the anticancer efficacy of doxorubicin","volume":"20","author":"Pakunlu","year":"2003","journal-title":"Pharm Res"},{"key":"10.1016\/j.lungcan.2006.06.019_bib6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2174\/1389450043345443","article-title":"Molecular targeting of drug delivery systems to cancer","volume":"5","author":"Minko","year":"2004","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.lungcan.2006.06.019_bib7","series-title":"The movement of molecules across cell membranes","author":"Stein","year":"1967"},{"key":"10.1016\/j.lungcan.2006.06.019_bib8","first-page":"1921","article-title":"A case of pulmonary adenocarcinoma with overexpression of multidrug resistance-associated protein and p53 aberration","volume":"20","author":"Nakamura","year":"2000","journal-title":"Anticancer Res"},{"key":"10.1016\/j.lungcan.2006.06.019_bib9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s004080000091","article-title":"Relationship between chemotherapy response of small cell lung cancer and P-glycoprotein or multidrug resistance-related protein expression","volume":"180","author":"Hsia","year":"2002","journal-title":"Lung"},{"key":"10.1016\/j.lungcan.2006.06.019_bib10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/1097-0215(20001015)88:2<293::AID-IJC23>3.0.CO;2-S","article-title":"Expression of the major vault protein LRP in human non-small cell lung cancer cells: activation by short-term exposure to antineoplastic drugs","volume":"88","author":"Berger","year":"2000","journal-title":"Int J Caner"},{"issue":"1","key":"10.1016\/j.lungcan.2006.06.019_bib11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/cyto.990200111","article-title":"Use of the biotinylated antibody DAKO-ER 1D5 to measure oestrogen receptor on cytokeratin positive cells obtained from primary breast cancer cells","volume":"20","author":"Brotherick","year":"1995","journal-title":"Cytometry"},{"issue":"10","key":"10.1016\/j.lungcan.2006.06.019_bib12","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1038\/bjc.1998.272","article-title":"The effect of 3-week tamoxifen treatment on oestrogen receptor levels in primary breast tumours: a flow cytometric study","volume":"77","author":"Brotherick","year":"1998","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.lungcan.2006.06.019_bib13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.5858\/2003-127-0461-TPROFC","article-title":"The potential role of flow cytometry in the diagnosis of small cell carcinoma","volume":"127","author":"Cornfield","year":"2003","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/j.lungcan.2006.06.019_bib14","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jtcvs.2005.05.012","article-title":"Intraoperative detection of lymph node micrometastasis with flow cytometry in non-small cell lung cancer","volume":"130","author":"Ito","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"8","key":"10.1016\/j.lungcan.2006.06.019_bib15","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/cyto.990120807","article-title":"Comparison of three commercially available antibodies for flow cytometric monitoring of P-glycoprotein expression in tumor cells","volume":"12","author":"Krishan","year":"1991","journal-title":"Cytometry"},{"issue":"13","key":"10.1016\/j.lungcan.2006.06.019_bib16","first-page":"3010","article-title":"Methods to detect P-glycoprotein-associated multidrug resistance in patients\u2019 tumors: consensus recommendations","volume":"56","author":"Beck","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2006.06.019_bib17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/jnci\/95.4.255","article-title":"Multidrug resistance: can new drugs help chemotherapy score against cancer?","volume":"95","author":"Goldman","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.lungcan.2006.06.019_bib18","first-page":"1086","article-title":"Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1\/P-glycoprotein, MRP1, and LRP in acute myeloid leukaemia: a Southwest Oncology Group study","volume":"94","author":"Leith","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.lungcan.2006.06.019_bib19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1634\/theoncologist.8-5-411","article-title":"The role of ABC transporters in clinical practice","volume":"8","author":"Leonard","year":"2003","journal-title":"Oncologist"},{"issue":"1\u20132","key":"10.1016\/j.lungcan.2006.06.019_bib20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0304-3835(98)00128-1","article-title":"Multidrug resistance genes (MRP) and MDR1 expression in small cell lung cancer xenografts: relationship with response to chemotherapy","volume":"130","author":"Canitrot","year":"1998","journal-title":"Cancer Lett"},{"key":"10.1016\/j.lungcan.2006.06.019_bib21","first-page":"619","article-title":"P-glycoprotein expression in ovarian cancer cell line following treatment with cisplatin","volume":"7","author":"Yang","year":"1995","journal-title":"Oncol Res"},{"key":"10.1016\/j.lungcan.2006.06.019_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00408-004-2532-1","article-title":"Comparison of chemotherapy response with P-glycoprotein, multidrug resistance-related protein expression in untreated small cell lung cancer","volume":"183","author":"Yeh","year":"2005","journal-title":"Lung"},{"key":"10.1016\/j.lungcan.2006.06.019_bib23","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/bjc.1997.154","article-title":"In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabine","volume":"75","author":"Jensen","year":"1997","journal-title":"Br J Cancer"},{"issue":"12","key":"10.1016\/j.lungcan.2006.06.019_bib24","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1038\/sj.bjc.6601011","article-title":"Increased sensitivity to gemcitabine of P-glycoprotein and multidrug resistance-associated protein-overexpressing human cancer cell lines","volume":"88","author":"Bergman","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lungcan.2006.06.019_bib25","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/jnci\/89.13.917","article-title":"Multidrug resistance in breast cancer: a meta-analysis MDR1\/P-gp 170 expression and its possible functional significance","volume":"89","author":"Trock","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.lungcan.2006.06.019_bib26","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/jcp.55.5.332","article-title":"Multidrug resistance related molecules in human and murine lung","volume":"55","author":"Scheffer","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.lungcan.2006.06.019_bib27","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1634\/theoncologist.8-5-411","article-title":"The role of ABC transporters in clinical practice","volume":"8","author":"Leonard","year":"2003","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.lungcan.2006.06.019_bib28","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/oxfordjournals.annonc.a010681","article-title":"Expression of the human major vault protein LRP in human lung cancer samples and normal lung tissues","volume":"7","author":"Dingemans","year":"1996","journal-title":"Ann Oncol"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500206003382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500206003382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T17:38:29Z","timestamp":1627753109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500206003382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0169500206003382"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2006.06.019","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}